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Abstract. 
 
The small GTPase Rho is believed to regu-
late the actin cytoskeleton and cell adhesion through its 
specific targets. We previously identified the Rho tar-
gets: protein kinase N, Rho-associated kinase (Rho-
kinase), and the myosin-binding subunit (MBS) of my-
osin phosphatase. We found that in MDCK epithelial 
cells, MBS accumulated at the tetradecanoylphorbol-
13-acetate (TPA)-induced membrane ruffling area, 
where moesin, a member of the ERM (ezrin, radixin, 
and moesin) family, was localized. Neither membrane 
ruffling nor an accumulation of moesin and MBS at the 
free-end plasma membrane was induced when MDCK 
cells were stimulated with TPA after the microinjection 
of C3, which ADP-ribosylates and inactivates Rho. 
MBS was colocalized with moesin at the cell–cell con-
tact sites in MDCK cells. We also found that moesin 
was coimmunoprecipitated with MBS from MDCK 
cells. Recombinant MBS interacted with the amino-ter-
minal domains of moesin and ezrin. Myosin phos-
phatase composed of the catalytic subunit and MBS 
showed phosphatase activity toward moesin, which was 
phosphorylated by Rho-kinase. The phosphatase activ-
ity was inhibited when MBS was phosphorylated by 
Rho-kinase. These results suggest that MBS is recruited 
with moesin to the plasma membrane and that myosin 
phosphatase and Rho-kinase regulate the phosphoryla-
tion state of moesin downstream of Rho.
 
T
 
he
 
 small GTPase Rho has GDP-bound inactive
(GDP·Rho) and GTP-bound active (GTP·Rho) forms
(Nobes and Hall, 1994; Takai et al., 1995). When
cells are stimulated with certain extracellular signals such
as lysophosphatidic acid, GDP·Rho is thought to be con-
verted to GTP·Rho, which binds to specific targets and
then exerts its biological functions. Rho participates in sig-
naling pathways that regulate actin cytoskeletons, such as
stress fibers, and cell substratum adhesions, such as focal
adhesions in fibroblasts (Ridley and Hall, 1992, 1994). Rho
is also involved in the regulation of cell morphology
(Paterson et al., 1990), cell aggregation (Tominaga et al.,
1993), cadherin-mediated cell–cell adhesion (Braga et al.,
1997), cell motility (Takaishi et al., 1994), cytokinesis (Kishi
et al., 1993; Mabuchi et al., 1993), membrane ruffling
(Nishiyama et al., 1994), smooth muscle contraction (Hirata
et al., 1992; Gong et al., 1996), c-
 
fos
 
 gene expression (Hill
et al., 1995), and the synthesis of phosphatidylinositol 4,5-
diphosphate (4,5-PIP
 
2
 
)
 
1
 
 via phosphatidylinositol 5-kinase
(PI5-kinase) (Chong et al., 1994). In budding yeast, RHO1
(a homologue of RhoA) is implicated in the regulation of
cell morphology and budding (Bussey, 1996). We identi-
fied three Rho targets: protein kinase N (Amano et al.,
1996
 
b
 
; Watanabe et al., 1996); Rho-associated kinase
(Rho-kinase) (Matsui et al., 1996), which was also identi-
fied as ROK
 
a
 
 (Leung et al., 1995); and the myosin-bind-
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ing subunit (MBS) of myosin phosphatase (Kimura et al.,
1996). p160 ROCK is an isoform of Rho-kinase (Ishizaki
et al., 1996). We showed that Rho-kinase phosphorylates
MBS and consequently inactivates myosin phosphatase
(Kimura et al., 1996). Rho-kinase also phosphorylates my-
osin light chain (MLC) and thereby activates myosin ATPase
in vitro (Amano et al., 1996
 
a
 
) and in vivo (Chihara et al.,
1997). Another group of investigators has identified differ-
ent Rho targets: Rhophilin, Rhotekin, citron, and mDia
(Madaule et al., 1995; Reid et al., 1996; Watanabe, G., et al.,
1996; Watanabe, N., et al., 1997). PI5-kinase is shown to be
activated by GTP·Rho (Chong et al., 1994). Among these
Rho targets, Rho-kinase appears to be involved in the for-
mation of stress fibers and focal adhesions (Leung et al.,
1996; Amano et al., 1997; Ishizaki et al., 1997), smooth
muscle contraction (Kureishi et al., 1997), and neurite re-
traction (Amano et al., 1998) downstream of Rho.
The ERM family, which consists of the three closely re-
lated proteins ezrin, radixin, and moesin, is thought to
function as cross-linking protein between plasma mem-
branes and actin filaments (Bretscher, 1983; Pakkanen et al.,
1987; Tsukita et al., 1989; Algrain et al., 1993; Arpin et al.,
1994). The ERM family is expressed and localized at the
specific regions where actin filaments are associated with
plasma membranes such as microvilli, ruffling membranes,
cell–cell adhesion sites, and cell–substratum adhesion sites
(Lankes et al., 1988; Tsukita et al., 1989, 1992; Sato et al.,
1991, 1992; Berryman et al., 1993; Amieva et al., 1994;
Takeuchi et al., 1994). The ERM family appears to be es-
sential for the interaction between plasma membranes and
actin filaments because the suppression of the ERM fam-
ily expression by antisense oligonucleotide disrupts mi-
crovilli, cell–cell adhesion sites, and cell–substratum adhe-
sion sites (Takeuchi et al., 1994). The NH
 
2
 
-terminal and
COOH-terminal domains of the ERM family are thought
to directly bind to some integral membrane proteins and
actin filaments, respectively (Tsukita et al., 1992; Turunen
et al., 1994; Pestonjamasp et al., 1995). Recently, it has
been reported that the NH
 
2
 
-terminal domain of ezrin is
also involved in F-actin binding (Roy et al., 1997). The
ERM family proteins are immunoprecipitated with CD44
from cultured cells (Tsukita et al., 1994). CD44 is a poly-
morphic cell surface glycoprotein that may serve as an ad-
hesion molecule (Haynes et al., 1989, 1991; Lesley et al.,
1993). CD44 is precisely colocalized with the ERM family,
and the cytoplasmic domain of CD44 interacts with the
ERM family in vitro, indicating that CD44 is one of the
membrane partners of the ERM family (Tsukita et al.,
1994; Hirao et al., 1996). Since the association of plasma
membranes with actin filaments is dynamically regulated,
the complex formation between CD44 and the ERM family
appears to be regulated dynamically. Consistently, recent
evidence suggests that Rho regulates the complex forma-
tion between CD44 and the ERM family, presumably through
4,5-PIP
 
2 
 
synthesis (Takaishi et al., 1995; Hirao et al., 1996).
In light of these observations, we examined the relation-
ship between moesin, a member of the ERM family, and
Rho targets. We found that MBS is colocalized with moesin
at the membrane ruffling area and cell–cell contact sites
and interacts with moesin both in vivo and in vitro, and
that myosin phosphatase and Rho-kinase regulate the
phosphorylation state of moesin.
 
Materials and Methods
 
Materials and Chemicals
 
MDCK cells were kindly provided by Dr. S. Tsukita (Kyoto University,
Kyoto, Japan) and maintained in DME containing 10% calf serum, strep-
tomycin, and penicillin. The expression plasmid of C3 transferase (pGEX-C3)
was kindly provided by Dr. A. Hall (University College, London, UK).
The cDNA encoding mouse moesin (1–577 amino acids [aa]) was kindly
provided by Dr. S. Tsukita (Hirao et al., 1996). Recombinant COOH-ter-
minal domain (307–577 aa) of mouse moesin (C-moesin), rat anti–moesin
mAb (M22), and mouse anti–moesin mAb (CR22) were kindly provided
by Dr. S. Tsukita (Takeuchi et al., 1994; Tsukita et al., 1994; Hirao et al.,
1996). Rabbit anti–rat MBS polyAb and chicken myosin phosphatase ho-
loenzyme were kindly provided by Dr. M. Ito (Mie University, Japan)
(Shimizu et al., 1994; Kimura et al., 1996). Anti–37-kD catalytic subunit of
myosin phosphatase polyAb and anti–Rho GDI polyAb were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Antihemagglutinin
(HA) mAb (12CA5) was purchased from Boehringer Mannheim (India-
napolis, IN). [
 
g
 
-
 
32
 
P]ATP and [
 
35
 
S]methionine were purchased from Amer-
sham Corp. (Buckinghamshire, UK). All materials used in the nucleic acid
study were purchased from Takara Shuzo Corp. (Kyoto, Japan). Other
materials and chemicals were obtained from commercial sources.
 
Preparation of Recombinant Proteins
 
C3, human ezrin (1–323 aa), human moesin (1–323 aa), and Rho-GDI
were expressed as glutathione-
 
S
 
-transferase (GST)
 
 
 
fusion
 
 
 
protein in 
 
Es-
cherichia coli
 
 and purified as described previously (Kikuchi et al., 1992;
Takeshima et al., 1994). For some experiments, human moesin (1–323 aa)
was expressed as GST-HA
 
 
 
fusion
 
 
 
protein in 
 
Escherichia coli
 
. Purified
GST-C3, GST-Rho GDI, and GST-HA-moesin (1–323 aa) was then
cleaved with thrombin to remove the GST according to the manufac-
turer’s instructions. GST-catalytic domain (6–553 aa) of Rho-kinase
(GST-CAT) was produced and purified from Sf9 cells as described previ-
ously (Matsuura et al., 1987; Amano et al., 1996
 
a
 
).
To obtain the recombinant full-length MBS, the cDNA encoding the
full-length rat MBS (Kimura et al., 1996) was inserted into the BamHI site
of pAcYMI. Also, the cDNA encoding mouse moesin (1–577 aa) was sub-
cloned into the KpnI site of pAcYMI-HA to yield HA-full-length moesin.
The full-length rat MBS and HA-full-length moesin were produced in
High Five and Sf9 cells, respectively, with the use of a baculovirus system
(Matsuura et al., 1987). The cells expressing the full-length rat MBS or
HA-full-length moesin were suspended in homogenizing buffer (20 mM
Tris/HCl, pH 8.0, 500 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 
 
m
 
M [
 
p
 
-ami-
dinophenyl]-methanesulfonyl fluoride [A-PMSF], 10 
 
m
 
g/ml leupeptin).
The suspensions were sonicated and centrifuged at 100,000 
 
g
 
 for 1 h at
4
 
8
 
C. The supernatants were diluted with buffer A (20 mM Tris/HCl, pH
7.5, 1 mM EDTA, 1 mM DTT) and applied onto Mono S or Mono Q col-
umn, respectively (Pharmacia LKB Biotechnology AB, Uppsala, Swe-
den), which had been equilibrated with buffer A. After the columns were
washed, the proteins were eluted with a linear concentration gradient of
NaCl (0–600 mM) in buffer A. Either MBS or HA-moesin was eluted with
about 200 mM NaCl. 
To obtain the in vitro–translated NH
 
2
 
- and COOH-terminal domains
of MBS, the cDNA fragments encoding the NH
 
2
 
-terminal domain (1–707
aa) and COOH-terminal domain (699–976 aa) of rat MBS were cloned
into the BamHI site of pCRII and pGEM-HA, respectively. The NH
 
2
 
-ter-
minal and COOH-terminal domains of rat MBS were translated in vitro
using the TNT T7-coupled reticulocyte lysate system (Promega Corp.,
Madison, WI) under the conditions described in the manufacturer’s in-
struction manual.
 
Immunofluorescence Analysis
 
MDCK cells were fixed with 3.7% formaldehyde in PBS for 10 min and
treated with PBS containing 0.2% Triton X-100 for 10 min. After being
washed with PBS three times, the cells were incubated with anti-MBS Ab
or antimoesin Ab (M22) for 1 h at room temperature. The cells were
washed with PBS three times, followed by incubation with FITC-conju-
gated anti–rabbit Ig Ab or FITC-conjugated anti–rat Ig Ab for 1 h at room
temperature. For double immunostaining, MDCK cells were incubated
with antimoesin Ab (M22) together with anti-MBS Ab for 1 h at room
temperature. Then MDCK cells were incubated with Texas red–conju-
gated anti–rat Ig Ab and FITC-conjugated anti–rabbit Ig Ab. After being 
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washed with PBS three times, the cells were examined using a laser scan-
ning confocal microscope (Carl Zeiss, Inc., Thornwood, NY). 
 
Microinjection
 
MDCK cells were seeded at the density of 2.5 
 
3 
 
10
 
3 
 
cells per 13-mm cover
glass in 60-mm tissue culture dishes and incubated for 8 h. Then, the cells
were deprived of serum for 24 h. For microinjection, C3 was concentrated,
and during the concentration the buffer was replaced by microinjection
buffer (20 mM Tris/HCl, pH 7.4, 20 mM NaCl, 1 mM MgCl
 
2
 
, 0.1 mM
EDTA, 5 mM 2-mercaptoethanol). 0.2 mg/ml C3 was microinjected along
with a marker protein (rabbit or mouse IgG at 1 mg/ml) into the cyto-
plasm of cells. 30 min after the microinjection, the cells were incubated in
DME containing 200 nM tetradecanoylphorbol-13-acetate (TPA) for 10
min at 37°C. MBS and moesin were visualized as described above. 
 
Immunoprecipitation Assay
 
MDCK cells were grown in 100-mm tissue culture dishes. After being
washed with PBS, the cells were lysed with 1 ml of extraction buffer (20 mM
Tris/HCl, pH 8.0, 150 mM NaCl, 5 mM MgCl
 
2,
 
 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, 0.1% NP-40, 10 
 
m
 
M A-PMSF, 10 
 
m
 
g/ml leupeptin).
The lysate was removed from the dishes with a rubber policeman, incu-
bated in a 1.5-ml tube for 15 min, and then clarified by centrifugation at
12,000 
 
g
 
 for 15 min. The soluble supernatant was incubated with 10 
 
m
 
l of
anti-MBS Ab or preimmuneserum. The immunocomplex was then precip-
itated with protein A–Sepharose CL 4B (Pharmacia LKB Biotechnology
AB). The immunocomplex was washed five times with the extraction
buffer containing 0.5% NP-40, eluted by boiling in sample buffer for SDS-
PAGE, and subjected to silver staining and immunoblot analysis using an-
timoesin Ab (CR22) as described (Harlow and Lane, 1988).
 
Interaction of Recombinant Full-Length MBS with 
Ezrin and Moesin in a Cell-free System
 
GST-ezrin (1–323 aa), GST-moesin (1–323 aa), and GST (150 pmol) were
separately immobilized onto 35 
 
m
 
l of glutathione–Sepharose 4B beads
(Pharmacia LKB Biotechnology AB). The immobilized beads were incu-
bated with the recombinant MBS (1–976 aa) (0.3 
 
m
 
M) in buffer A contain-
ing 1 mg/ml BSA for 1 h at 4
 
8
 
C. The beads were washed six times with 116 
 
m
 
l
(3.3 vol) of buffer A, and the bound proteins were eluted three times with
GST-ezrin and GST-moesin by the addition of 116 
 
m
 
l (3.3 vol) of buffer A
containing 10 mM glutathione. The first eluates were subjected to SDS-
PAGE, and the proteins were detected by silver staining. For some exper-
iments, HA-moesin (1–323 aa) and GST-HA-moesin (1–323 aa) (50 pmol
each) were separately immobilized onto protein A–Sepharose CL 4B (20 
 
m
 
l)
with anti-HA mAb and incubated with MBS (0.3 
 
m
 
M). HA-full-length
moesin was also immobilized the same as HA-moesin (1–323 aa). Instead
of MBS, Rho GDI (2.0 
 
m
 
M) was incubated with HA-full-length moesin or
GST-moesin (1–323 aa) (50 pmol each) immobilized beads and the bound
Rho GDI were detected by immunoblotting. For 
 
K
 
d
 
 estimation, 50 pmol
of GST-moesin (1–323 aa) or HA-full-length moesin–immobilized beads
(20 
 
m
 
l) were incubated with the various concentration of MBS in 100 
 
m
 
l of
buffer A containing 50 mM NaCl and 1 mg/ml BSA. The amount of bound
MBS to each moesin was detected by Coomassie brilliant blue staining
and estimated with a densitograph (ATTO, Tokyo, Japan). 
 
In Vitro Binding Assay between NH
 
2
 
- and
COOH-terminal Domains of MBS and Ezrin
 
The in vitro–translated NH
 
2
 
- and COOH-terminal domains of MBS were
separately incubated with GST-ezrin (1–323 aa) or GST (1 nmol each) im-
mobilized beads, and the bound proteins were eluted as described above.
The eluates were subjected to SDS-PAGE and vacuum-dried, followed by
autoradiography. 
 
Interaction of Myosin Phosphatase with Ezrin
and Moesin
 
Bovine brain membrane extract was obtained as described previously
(Amano et al., 1996
 
b
 
). The extract was loaded onto 0.25 ml glutathione-
Sepharose columns containing 6.5 nmol of GST-ezrin and GST-moesin.
After the columns were washed with 0.85 ml (3.3 vol) of buffer A and then
0.85 ml (3.3 vol) of buffer A containing 50 mM NaCl, three times with
each, the bound proteins were eluted three times by the addition of 0.85
ml (3.3 vol) of buffer A containing 10 mM glutathione. The first eluates
were subjected to silver staining or immunoblot analysis using antibodies
against the MBS and the 37-kD catalytic subunit of myosin phosphatase.
 
Protein Phosphatase Assay
 
C-moesin (300 ng of protein) was phosphorylated with GST-CAT (120 ng
of protein) in 20 
 
m
 
l of kinase buffer (50 mM Tris/HCl, pH 7.5, 5 mM
MgCl
 
2, 
 
1 mM EDTA, 1 mM EGTA, 1 mM DTT) containing 100 
 
m
 
M
[
 
g
 
-
 
32
 
P]ATP for 1 h at 30
 
8
 
C, and the reaction was stopped by the addition
of 200 nM staurosporine. Native myosin phosphatase (5–75 ng) was prein-
cubated in 30 
 
m
 
l of reaction mixture containing 0.3 mM CoCl
 
2, 
 
with or
without 100 
 
m
 
M adenosine 5
 
9
 
-
 
O
 
-(3-thiotriphosphate) (ATP
 
g
 
S) in the
presence of GST-CAT (80 ng of protein) for 15 min at 30
 
8
 
C, and the reac-
tion was stopped by the addition of 200 nM staurosporine. The phos-
phatase reaction was then performed in 50 
 
m
 
l of the reaction mixture (30
mM Tris/HCl, pH 7.5, 3 mM MgCl
 
2, 
 
0.4 mM EDTA, 0.55 mM EGTA, 0.1
mg/ml BSA, 5–75 ng of myosin phosphatase preincubated as described
above, 300 ng of 
 
32
 
P-labeled C-moesin) for 15 min at 30
 
8
 
C. The reaction
mixture was then boiled in sample buffer for SDS-PAGE and resolved by
SDS-PAGE. The 
 
32
 
P-labeled band corresponding to C-moesin was visual-
ized and estimated with an image analyzer (model BAS-2000; Fuji, Tokyo,
Japan).
 
Other Procedures
 
SDS-PAGE was performed as described (Laemmli, 1970). Protein con-
centrations were determined with BSA as the reference protein as de-
scribed (Bradford, 1976).
 
Results
 
Colocalization of MBS and Moesin at the TPA-induced 
Membrane Ruffling Area in MDCK Cells 
 
Rho is believed to be involved in the hepatocyte growth
factor– and phorbol ester–induced membrane ruffling in
MDCK and KB epithelial cells (Nishiyama et al., 1994; Ta-
kaishi et al., 1995). Rho and the ERM family are localized
at the TPA-induced membrane ruffling area (Takaishi et al.,
1995). We examined whether MBS is localized at the TPA-
induced membrane ruffling area. When serum-starved
MDCK cells were stimulated with TPA, membrane ruf-
fling was induced within 10 min, and moesin (one of the
ERM family) accumulated at the membrane ruffling area
as previously shown (Takaishi et al., 1995) (Fig. 1 
 
A
 
). MBS
also accumulated at the membrane ruffling area and was
colocalized with moesin (Fig. 1 
 
A
 
). The TPA-induced
membrane ruffling is inhibited by a prior microinjection of
C3, which ADP-ribosylates and inactivates Rho (Takaishi
et al., 1995). When serum-starved MDCK cells were stim-
ulated with TPA 30 min after a microinjection of C3, nei-
ther membrane ruffling nor the accumulation of moesin
and MBS at the free-end plasma membrane was induced
(Fig. 1 
 
B
 
).
We have recently shown that MBS accumulates at cell–
cell contact sites apart from myosin fibers in polarized
MDCK epithelial cells, whereas MBS is colocalized with
myosin fibers in REF52 fibroblasts (Inagaki et al., 1997).
The ERM family and Rho are localized at the cell–cell
contact sites of MDCK epithelial cells, and the activity of
the ERM family is thought to be regulated by Rho (Takai-
shi et al., 1995; Hirao et al., 1996; Kotani et al., 1997). We
then compared the localization of MBS with that of
moesin in confluent MDCK cells. A high level of MBS im-
munoreactivity was observed at the basolateral membrane 
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of the cell–cell contact sites but not at a free end and
showed a granular dotlike pattern as found earlier (Ina-
gaki et al., 1997). Double immunofluorescence analysis re-
vealed that MBS showed a distribution similar to that of
moesin at the basolateral membrane of cell–cell contact
sites (data not shown). On the other hand, MBS was not
localized at the microvilli of the apical membrane, where
moesin was concentrated. The localization of MBS was
different from that of ZO-1 as a molecular marker of tight
junctions, which showed a thin beltlike pattern and the lo-
calization at the apical side of cell–cell contact sites as pre-
viously described (Stevenson et al., 1986) (data not shown).
These results indicate that MBS is partly colocalized with
moesin in MDCK cells. 
 
Complex Formation between MBS and Moesin 
 
Because the localization and behavior of MBS are partly
Figure 1. Colocalization of
MBS and moesin at mem-
brane ruffling area in MDCK
cells. (A) Colocalization of
MBS and moesin at the TPA-
induced ruffling area. Serum-
starved MDCK cells were
stimulated with 200 nM TPA
and doubly stained with anti-
MBS Ab and antimoesin Ab
(M22), followed by FITC-
conjugated anti–rabbit Ig
Ab for MBS and Texas red–
conjugated anti–rat Ig Ab for
moesin and analyzed by a
confocal microscopy. (a–c)
Nonstimulated serum-starved
MDCK cells. (d–f) Serum-
starved MDCK cells stimu-
lated with TPA. (a and d)
Phase-contrast images (b
and  e), MBS staining, and (c
and f) moesin staining. (B)
Inhibition of the TPA-induced
translocation of MBS and
moesin by C3. Microinjection
with 0.2 mg/ml C3 and TPA
stimulation were performed
as described in Materials and
Methods. After TPA stimu-
lation, cells were stained with
anti-MBS Ab (b) or anti-
moesin Ab (e), followed by
FITC-conjugated anti–rabbit
Ig Ab for MBS and FITC-
conjugated anti–rat Ig Ab
for moesin. The mouse IgG
or rabbit IgG microinjected
as a marker with C3 were
stained by Texas red–conju-
gated anti–mouse (c) or rab-
bit (f) Ig Ab, and microin-
jected cells were indicated.
The arrowheads indicate the
microinjected cells. (a and d)
Phase-contrast images. The
results shown are representa-
tive of three independent ex-
periments. Bars, 10 mm.  
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similar to those of moesin in MDCK cells, we examined
whether MBS forms a complex with the ERM family in
vivo. From the lysate of MDCK cells, MBS was immuno-
precipitated with anti-MBS antibody, and the immunopre-
cipitates were subjected to immunoblot analysis to detect
the ERM family. The immunoreactive band was detected
in the immunoprecipitate with anti-MBS antibody (Fig. 2 
 
B
 
).
Because the mAb CR22 predominantly reacts to moesin
of the ERM family members in immunoblotting (Tsukita
et al., 1994), the immunoreactive band was likely to corre-
spond to moesin under these conditions. About 10% of
the total MBS was immunoprecipitated, and about 0.5%
of the total moesin was recovered with the immunoprecip-
itated MBS under the conditions. Moesin appeared to as-
sociate with MBS with a stoichiometry of about one
moesin per three MBS in the immunoprecipitates. Little
moesin was immunoprecipitated with control preimmunese-
rum or without antibody. Similar results were obtained
when MBS was immunoprecipitated from KB cells instead
of MDCK cells (data not shown). Using the other antibod-
ies that can specifically react with each member of the
ERM family, we examined whether ezrin and radixin
other than moesin were coimmunoprecipitated with MBS
from MDCK cells. Under the conditions, neither ezrin nor
radixin was detected in the immunoprecipitate with anti-
MBS antibody (data not shown). Radixin appeared to be
undetectable in the immunoprecipitate with anti-MBS an-
tibody because only ezrin and moesin but not radixin were
detected in the start lysate of the MDCK cells. MDCK
cells may express radixin in a small amount. We do not
know the exact reason why ezrin was not coimmunopre-
cipitated with MBS. 
Since in the ERM family members the amino acid se-
quence of their NH
 
2
 
-terminal halves (
 
z
 
300 aa) is highly
conserved (
 
z
 
85% identity for any pair) (Sato et al., 1992),
we tested whether MBS binds directly to the NH
 
2
 
-terminal
domain of ezrin and moesin in a cell-free system. The puri-
fied recombinant MBS (1–976 aa) was incubated with
GST-ezrin (1–323 aa), GST-moesin (1–323 aa), or GST-
immobilized beads. After washing the beads, the GST fu-
sion proteins were eluted by the addition of glutathione.
Recombinant MBS was coeluted with GST-ezrin (1–323
aa) and GST-moesin (1–323 aa), but not with GST (Fig. 3 
 
A
 
).
To confirm that the NH
 
2
 
-terminal domain of moesin with-
out GST shows the same behavior as GST-NH
 
2
 
-terminal
domain of moesin (1–323 aa), we produced HA-NH
 
2
 
-ter-
minal domain of moesin (1–323 aa) by cleaving GST of
GST-HA-moesin (1–323 aa). Fig. 3 
 
B
 
 shows that MBS
bound not only to GST-HA-moesin (1–323 aa) but also to
HA-moesin (1–323 aa). We confirmed that using a gel fil-
tration chromatography, MBS bound to the untagged
NH
 
2
 
-terminal domain of moesin (1–323 aa) stoichiometri-
cally (data not shown). Because moesin was coimmuno-
precipitated with MBS from the cultured cells, we next
tested whether recombinant MBS also binds to the full-
length moesin. Recently, Rho GDI has been reported to
bind to the NH
 
2
 
-terminal domain of the ERM family but
not to the full-length ERM family (Takahashi et al., 1997).
HA-tagged full-length moesin (1–577 aa) was produced by
use of a baculovirus system. As shown in Fig. 3 
 
C
 
, MBS
bound to full-length moesin, whereas Rho GDI did not
bind to full-length moesin as previously described (Taka-
hashi et al., 1997). We further performed the kinetic study
on the binding of MBS to moesin. As shown in Fig. 3 
 
D
 
,
purified MBS bound to GST-moesin (1–323 aa) and HA-
full-length moesin (1–577 aa) in a dose-dependent man-
ner, and the interactions were almost saturable under the
conditions. The 
 
K
 
d values for the binding of MBS to GST-
moesin (1–323 aa) and HA-full-length moesin (1–577 aa)
were 0.26 6 0.03 and 1.23 6 0.09 mM, respectively. The
stoichiometry of the binding of MBS to GST-moesin (1–
323 aa) was about 0.4. Although we do not know the exact
reason why the stoichiometry did not reach to about one,
either recombinant MBS or moesin may not be completely
renatured. We also carried out this assay at a physiological
ionic strength (at 150 mM NaCl). The Kd value for the
binding of MBS to GST-moesin (1–323 aa) at 150 mM
NaCl was about the same as that under the above condi-
tions (at 50 mM NaCl) (data not shown).
To identify the region responsible for MBS binding in
the NH2-terminal domain of moesin, we produced further
truncated constructs of the NH2-terminal domain of moesin
as GST fusion proteins. MBS could not bind to the NH2-
terminal moesin that lacked at least the region between
amino acids 234 and 323 (data not shown). This result indi-
cates that the region between amino acids 234 and 323 is
important for MBS binding to moesin. Recently, the regu-
latory subunit of protein kinase A type II (RII) has been
reported to bind to ezrin through an amphipathic helix lo-
cated between residues 417–430 and also to bind to moesin
and radixin (Dransfield et al., 1997). It is likely that MBS
and RII bind to the distinct regions of moesin.
We further examined which domain of MBS interacts
with the NH2-terminal domain of the ERM family using
the in vitro–translated NH2- and COOH-terminal domains
of MBS. Immobilized GST-ezrin (1–323 aa) was mixed
with the in vitro–translated NH2- or COOH-terminal do-
main of MBS, and interacting proteins were eluted with
GST-ezrin by the addition of glutathione. As shown in Fig.
Figure 2. Coimmunoprecipitation of moesin with MBS. MDCK
cells were lysed and solubilized with extraction buffer. This sam-
ple was incubated without antibody, with preimmuneserum, or
with anti-MBS Ab. Then, the immunocomplexes were precipi-
tated with protein A–Sepharose 4B. The immunocomplexes were
subjected to silver staining (A) and immunoblot analysis using
antimoesin Ab (CR22) (B). The arrow and arrowhead denote the
positions of MBS and moesin, respectively. The results shown are
representative of three independent experiments.The Journal of Cell Biology, Volume 141, 1998 414
4, the COOH-terminal domain of MBS bound to the NH2-
terminal domain of ezrin, whereas the NH2-terminal do-
main of MBS did not bind. Essentially identical results
were obtained when GST-moesin (1–323 aa) was used in-
stead of GST-ezrin (1–323 aa) (data not shown), indicating
that the COOH-terminal domain of MBS is responsible
for the binding of MBS to the NH2-terminal domain of the
ERM family. Taken together, these findings indicate that
MBS binds to ezrin and moesin of the ERM family in vitro
and at least to moesin in vivo, and the interaction is spe-
cific and physiological.
Phosphatase Activity of Myosin Phosphatase toward 
Moesin Phosphorylated by Rho-Kinase
It has been reported that in thrombin-activated platelets,
moesin is phosphorylated at Thr558 (Nakamura et al.,
1995). Thr558 is located in the sequence K555YKTL559,
which is highly conserved among the ERM family and is
involved in the actin binding of the ERM family (Turunen
et al., 1994; Pestonjamasp et al., 1995). By further analysis
using phosphorylation site–specific antibody, it is specu-
lated that the phosphorylation at Thr558 of moesin is re-
quired for the stable interaction with actin of moesin at
filopodia (Nakamura et al., 1996). In the preceding paper
(Matsui et al., 1998), we found that Rho-kinase phosphor-
ylates the ERM family. The phosphorylation site of moesin
by Rho-kinase is identified as Thr558.
We speculated that myosin phosphatase might also reg-
ulate the phosphorylation states of moesin downstream of
Rho, as described for MLC (Kimura et al., 1996). We
tested whether only the MBS or also the 37-kD catalytic
subunit of myosin phosphatase interacts with ezrin and
moesin, using GST-ezrin (1–323 aa) and GST-moesin (1–
323 aa) affinity columns (Fig. 5). Bovine brain membrane
extract was loaded onto a glutathione-Sepharose affinity
column on which GST, GST-ezrin, or GST-moesin was
immobilized. The proteins bound to the affinity columns
were then coeluted with GST fusion proteins by the addi-
tion of glutathione. Fig. 5 A shows some molecules inter-
acted with the NH2-terminal domain of ezrin and moesin
(1–323 aa). Immunoreactive bands corresponding to the
catalytic subunit as well as MBS were specifically detected
in the eluates from the GST-ezrin and GST-moesin affin-
ity columns (Fig. 5 B). We estimated that MBS and the
catalytic subunit were about 20-fold enriched on GST-
ezrin and GST-moesin affinity columns from bovine brain
membrane extract. This result indicates that myosin phos-
phatase composed of MBS and the catalytic subunit inter-
acts with ezrin and moesin, presumably through MBS.
We next examined whether myosin phosphatase de-
phosphorylates moesin that is phosphorylated by Rho-
Figure 3. Direct interaction
between MBS and ezrin or
moesin in a cell-free system.
(A) Interaction of recombi-
nant MBS and GST-ezrin (1–
323 aa) or GST-moesin (1–
323 aa). Purified MBS (1–976
aa) was incubated with GST-
ezrin (1–323 aa), GST-moesin
(1–323 aa), or GST-immobi-
lized beads. After being washed
by buffer A, the bound pro-
teins were eluted with GST
fusion proteins by the addition of glutathione. The eluates were subjected to
SDS-PAGE and detected by silver staining. The arrow denotes the position of
the recombinant MBS (1–976 aa). The arrowheads denote the positions of
GST-ezrin or GST-moesin. (B) Interaction of recombinant MBS and HA-
moesin (1–323 aa) without GST. Purified MBS (1–976 aa) was incubated with
the protein A–Sepharose on which HA-moesin (1–323 aa) or GST-HA-moesin
(1–323 aa) were immobilized with anti-HA mAb. As the control beads, anti-
HA mAb alone was separately immobilized. After being washed with buffer A,
the bound proteins were eluted by buffer A containing 500 mM NaCl and de-
tected by silver staining. The arrow denotes the position of the recombinant
MBS (1–976 aa). (C) Interaction of recombinant MBS and HA-full-length
moesin (1–577 aa). Purified MBS (1–976 aa) and Rho GDI were separately in-
cubated with the protein A–Sepharose which HA-full-length moesin was immo-
bilized with anti-HA mAb. As the control beads, anti-HA mAb alone was sepa-
rately immobilized. Also, purified MBS and Rho GDI were separately
incubated with the glutathione Sepharose 4B on which GST or GST-moesin (1–
323 aa) was immobilized. After being washed with buffer A, the bound MBS
and Rho GDI were eluted as described above and detected by immunoblot
analysis. The results shown are representative of three independent experi-
ments. (D) The kinetic study of the MBS binding to the NH2-terminal domain
of moesin and the full-length moesin. The various doses of MBS (1–976 aa)
were incubated with 50 pmol of GST-moesin (1–323 aa) (white boxes) or HA-
full-length moesin (1–577 aa) (black boxes) immobilized beads in 100 ml of buffer A containing 50 mM NaCl. The amount of bound
MBS was plotted after subtraction of the background binding to control beads. The values shown are means 6 SE of triplicates.Fukata et al. Moesin and Rho Targets 415
kinase. The myosin phosphatase showed phosphatase
activity toward the C-moesin (307–577 aa), which was
phosphorylated by Rho-kinase (Fig. 6). The myosin phos-
phatase also showed phosphatase activity toward full-
length moesin (data not shown). We previously observed
that the MBS of the native myosin phosphatase is thio-
phosphorylated with Rho-kinase in the presence of ATPgS
and that this thiophosphorylation of MBS is associated
with a decrease of phosphatase activity toward MLC
(Kimura et al., 1996). Here, we examined whether Rho-
kinase also modulates the phosphatase activity of myosin
phosphatase toward moesin through the thiophosphoryla-
tion of MBS. We found that the thiophosphorylation of
MBS by Rho-kinase was associated with a decrease of
phosphatase activity toward C-moesin, although the inhi-
bition of phosphatase activity was not strong (Fig. 6).
Discussion
Colocalization of MBS and Moesin at the TPA-induced 
Membrane Ruffling Area 
The ERM family members, which belong to the band 4.1
family, are thought to act as cross-linkers between plasma
membranes and actin filaments (Tsukita et al., 1989; Al-
grain et al., 1993; Arpin et al., 1994). The ERM family and
Rho are localized at specialized plasma membrane areas,
including cell–cell contact sites and membrane ruffling area
of MDCK epithelial cells (Takaishi et al., 1995). The trans-
location of the ERM family to the plasma membranes is
thought to be regulated by Rho (Takaishi et al., 1995;
Hirao et al., 1996; Kotani et al., 1997). Here we showed
that MBS is colocalized with moesin at the TPA-induced
membrane ruffling area (Fig. 1) and cell–cell contact sites
in MDCK epithelial cells and that myosin phosphatase in-
teracts with ezrin and moesin (Fig. 5) and dephosphory-
lates moesin, which is phosphorylated by Rho-kinase (Fig.
6). Thus, it is likely that MBS regulates the state of phos-
phorylation of at least moesin of the ERM family at spe-
cialized areas of plasma membranes, such as ruffling area
and cell–cell contact sites. On the other hand, the ERM
family has been shown to be located at the microvilli of the
apical membrane (Bretscher, 1983; Berryman et al., 1993),
where MBS does not accumulate. Also, MBS has been
shown to be localized with myosin in the stress fibers in
REF52 fibroblasts (Inagaki et al., 1997), whereas the ERM
family is not localized in the stress fibers. This observation
is reasonable because MBS is isolated as the myosin-bind-
ing subunit of myosin phosphatase. We also assume that
moesin is one of the substrates of myosin phosphatase, and
it is not necessary for the enzyme to be completely colocal-
ized with its substrates. These observations mean that
MBS is colocalized with some part of moesin at the spe-
cialized area of plasma membranes such as ruffling area
and cell–cell contact sites. 
Complex Formation between MBS and Moesin
The ERM family interacts with some integral membrane
proteins via their NH2-terminal domains, and with F-actin
via their NH2- and COOH-terminal domains (Algrain et al.,
1993; Roy et al., 1997). We showed that some population
of moesin interacts with MBS in vivo and that MBS inter-
acts with the NH2-terminal domains of ezrin and moesin in
vitro (Figs. 2–5). The efficiency of coimmunoprecipitation
of moesin with MBS is not so high. Nevertheless, we con-
sider this interaction physiological because the enzyme–
substrate interaction is usually labile, and MBS is colocal-
ized with moesin at the membrane ruffling area and the
cell–cell contact sites but not at the microvilli. We did not
detect ezrin or radixin in the immunoprecipitates of MBS.
Figure 4. Binding of the COOH-terminal domain of MBS to the
NH2-terminal domain of ezrin. The in vitro–translated NH2- or
COOH-terminal domain of MBS was incubated with GST-ezrin
(1–323 aa) or GST-immobilized beads. After the beads were
washed, the bound proteins were eluted with GST-ezrin or GST
by the addition of glutathione. The eluates were subjected to
SDS-PAGE and vacuum-dried, followed by autoradiography.
The in vitro–translated NH2-terminal (arrow) and COOH-termi-
nal (arrowhead) domains of MBS were shown. The results shown
are representative of three independent experiments.
Figure 5. Specific interaction of myosin phosphatase with ezrin
and moesin. Bovine brain membrane extract was loaded onto
0.25 ml of glutathione-Sepharose columns containing 6.5 nmol of
GST-ezrin (1–323 aa), GST-moesin (1–323 aa), or GST. After the
columns were washed, the proteins were eluted by the addition of
glutathione. The eluates were subjected to silver staining (A) and
immunoblot analysis (B) using antibodies against MBS (B, top)
and the 37-kD catalytic subunit of myosin phosphatase (B, bot-
tom). (A) The arrow denotes the position of MBS. The arrow-
heads denote the positions of GST-ezrin (1–323 aa) or GST-
moesin (1–323 aa). (B) The arrow denotes the position of MBS.
The arrowhead denotes the position of the 37-kD catalytic sub-
unit of myosin phosphatase. The results shown are representative
of three independent experiments.The Journal of Cell Biology, Volume 141, 1998 416
As described in Results, the exact reason for this result is
not known, but we cannot conclude that MBS binds only
to moesin out of the ERM family because the NH2-termi-
nal domain of the ERM family is highly conserved and
MBS also binds to the NH2-terminal domain of ezrin in
vitro. It is possible that the anti-MBS antibody preferen-
tially immunoprecipitated the MBS/moesin complex.
The NH2- and COOH-terminal domains of the ERM
family are thought to oppose each other, presumably
through the head to tail association between the NH2- and
COOH-terminal domains (Martin et al., 1995, 1997; Gary
and Bretscher, 1995; Hirao et al., 1996). This interdomain
association is thought to be released by acidic phospholip-
ids such as 4,5-PIP2 (Hirao et al., 1996). Once the ERM
family is activated, it appears to be translocated from the
cytosol to the plasma membrane, where it serves as a
cross-linker between actin filaments and its membrane
partners, such as CD44 (Tsukita et al., 1994). Rho GDI
has consistenly been shown to interact with the NH2-ter-
minal domain of the ERM family but not with the full-
length of the ERM family (Takahashi et al., 1997). We
confirmed its observation (Fig. 3 C). On the other hand,
Dransfield et al. (1997) has reported that RII binds to the
full-length ezrin. Also, we found that MBS can stoichio-
metrically interact with the full-length moesin, although
the affinity of MBS to the full-length moesin is lower than
that to the NH2-terminal domain of moesin (Fig. 3 D).
Thus, the simple head to tail interaction model cannot
fully explain why the MBS/full-length moesin and RII/full-
length ezrin interaction occur in vitro under the conditions
where  Rho GDI does not interact with the full-length
ERM family. Although it is unknown whether MBS and
RII bind to the ERM family in its inactive states in vivo
and are required for the activation of the ERM family, this
point may be important to clarify the activation process of
the ERM family. Further studies are necessary to under-
stand this point.
Is Moesin Activated by MBS? 
Since the activity of the ERM family is thought to be regu-
lated by Rho, and MBS is one of the Rho targets, we can
speculate that MBS interacts with and activates moesin
and is translocated with moesin to the plasma membrane.
However, this may not be likely because the translocation
of moesin is not induced when the myristoylated form of
MBS is expressed in MDCK cells and is targeted to the
plasma membrane (data not shown). This means that the
MBS translocation is not sufficient for the translocation of
moesin to the membrane. When MDCK cells are stimu-
lated with TPA, the membrane ruffling is induced and the
ERM family is translocated to the plasma membrane of
ruffling area. This action of TPA may be mediated by Rho
because the TPA-induced membrane ruffling is prevented
by a prior microinjection of C3 transferase. The transloca-
tion of the ERM family to the plasma membrane requires
the Rho function in vitro (Hirao et al., 1996). Taken to-
gether, these observations suggest that the activation of
the ERM family is regulated by Rho. Further studies are
necessary for a better understanding of the involvement of
MBS in Rho-mediated ERM activation. Other Rho tar-
gets such as PI5-kinase may be responsible for the activa-
tion of the ERM family through the synthesis of 4,5-PIP2
(Hirao et al., 1996).
Dual Regulation of the Phosphorylation State
of Moesin
Rho regulates MLC phosphorylation via two pathways
through its targets, Rho-kinase and MBS, as follows. Acti-
vated Rho interacts with Rho-kinase and the MBS of myo-
sin phosphates and activates Rho-kinase. The activated
Rho-kinase subsequently phosphorylates MBS, thereby
inactivating myosin phosphatase (Kimura et al., 1996).
Rho-kinase by itself phosphorylates MLC at the same site
that is phosphorylated by MLC kinase, and activates myo-
sin ATPase (Amano et al., 1996a). The phosphorylation of
MLC results in the contraction of smooth muscle or the in-
teraction of actin and myosin in nonmuscle cells, leading
to stress fiber formation (Kamm and Stull, 1985; Hart-
shorne, 1987; Sellers and Adelstein, 1987; Giuliano and
Taylor, 1995). The expression of the dominant active form
of Rho-kinase in cells consistently induces the formation
of stress fibers and focal adhesions (Leung et al., 1996;
Amano et al., 1997; Ishizaki et al., 1997). We confirmed
that the phosphorylation state of MLC is dually regulated
through myosin phosphatase and Rho-kinase in permeabi-
lized smooth muscle (Kureishi et al., 1997) and COS7 cells
(Chihara et al., 1997). We also found that Rho-kinase
phosphorylates the ERM family and that the phosphoryla-
tion of radixin by Rho-kinase inhibits the interdomain as-
sociation between the NH2- and COOH-terminal domains
of radixin (Matsui et al., 1998). This result suggests that
the phosphorylation of the ERM family by Rho-kinase
may release the interdomain suppression between the
NH2- and COOH-terminal domains or may maintain the
activity of the ERM family by interfering with the interdo-
main association. Here we showed that myosin phos-
phatase composed of MBS and the catalytic subunit spe-
cifically interacts with ezrin and moesin (Fig. 5). We also
showed that myosin phosphatase dephosphorylates moesin,
which is phosphorylated by Rho-kinase (Fig. 6). The phos-
phatase activity of myosin phosphatase toward moesin is
Figure 6. Phosphatase activ-
ity of myosin phosphatase to-
ward moesin. C-moesin was
phosphorylated with GST-
CAT as described in Materi-
als and Methods. After the
indicated amounts of myosin
phosphatase were incubated
with (white triangles) or with-
out (black traingles) ATPgS
in the presence of GST-CAT,
the phosphatase activity to-
ward the phosphorylated
C-moesin was assayed for 10
min at 308C. The reaction
mixture was then boiled in
sample buffer for SDS-PAGE and resolved by SDS-PAGE. The
32P-labeled bands corresponding to C-moesin were visualized,
and the amounts of 32P-labeled C-moesin were estimated with an
image analyzer (model BAS-2000; Fuji). The values shown are
means 6 SE of triplicates.Fukata et al. Moesin and Rho Targets 417
inhibited by the thiophosphorylation of MBS with Rho-
kinase (Fig. 6). These results mean not only that MBS is
one of the new partners of moesin but also that the phos-
phorylation level of moesin is dually regulated through
myosin phosphatase and Rho-kinase downstream of Rho
in a manner similar to MLC. Taken together, it is likely
that Rho can regulate the activity of moesin at least by
regulating its phosphorylation state through MBS and
Rho-kinase.
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